Pharma Articles
Renowned pharmaceutical firm executives and other experts from around the world write articles on current topics in the industry. The section of articles on the pharmaceutical sector focuses on contemporary and expanding challenges in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
The pharmaceutical sector is experiencing a radical change with the focus now being on patientfocused pharma strategies instead of productbased approaches Patients are not the passive consumers of healthcare anymore they are informed participants in the healthcare business environment and seek to ac...
The pharmaceutical sector is at crossroads On the one hand it is the huge task of creating lifesaving drugs and on the other an unquestionably large pressure on minimizing the harm that drug production can cause to the environment This is where green chemistry in the pharmaceutical sector comes into...
The United States pharmaceutical sector is experiencing one of the most dramatic changes of the recent decades As new US drug pricing reforms in and changing pharmaceutical tariffs redefine the financial health of Big Pharma it is being transformed Policies to lower the cost of medicine to patients...
An organisations quality culture is reflected in its quality metrics Metrics reveal how the organisation really values quality how quickly it acts on a deviation and whether it is truly solving problems or just managing temporary fixesWhat does this look like Here is an example of a sterile facility...
Every clinical milestone from patient enrollment to regulatory submissiondepends on informed operational decisions grounded in data risk assessment and compliance with evolving global regulations The current operational landscape includes decentralised trials realworld evidence integration wearable...
The traditional clinical trial model has historically prioritized operational efficiency and regulatory compliance often at the expense of patient convenience and engagement Traditional sitecentric trials typically rely on frequent inperson visits narrowly defined eligibility criteria and endpoints...
Cancer remains one of the most complex and challenging diseases confronting modern medicine Despite decades of research and progress its global burden persists necessitating a constant evolution of treatment strategies Traditional cytotoxic chemotherapy and radiation have saved and extended countles...
In carbon reduction strategies of pharmaceutical production have shifted to the compulsory operating requirements The pharmaceutical sector once essentially concerned with accuracy security and regulatory compliance is now being pushed to develop in not merely treatment innovativeness yet in sustai...
As fast approaches the pharmaceutical sector faces increasing pressure to align with the United Nations Sustainable Development Goals With climate change now a central global concern the industry must take decisive action to cut emissions and operate more responsibly both environmentally and econo...
In the changing life science industry pharma companies lead generation has been the most tasking and competitive ever As opposed to the BC models the pharmaceutical ecosystem centricity is an area of BB leads generation in pharma industries where hospitals distributors healthcare providers CROs and...